Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

Cullinan Therapeutics (CGEM) Tax Provisions (2022 - 2023)

Cullinan Therapeutics (CGEM) has 1 years of Tax Provisions data on record, last reported at -$1.9 million in Q4 2022.

  • For Q4 2022, Tax Provisions changed N/A year-over-year to -$1.9 million; the TTM value through Sep 2023 reached $64.2 million, changed N/A, while the annual FY2024 figure was $117000.0, 100.83% up from the prior year.
  • Tax Provisions reached -$1.9 million in Q4 2022 per CGEM's latest filing, down from $66.1 million in the prior quarter.
  • Across five years, Tax Provisions topped out at $66.1 million in Q2 2022 and bottomed at -$1.9 million in Q4 2022.